NCT00199836View on ClinicalTrials.gov

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 3, 2003

Primary Completion Date

September 5, 2005

Study Completion Date

June 6, 2006

Conditions
CancerNeoplasm
Interventions
BIOLOGICAL

NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51

Trial Locations (1)

Unknown

Krankenhaus Nordwest, Frankfurt

Sponsors
All Listed Sponsors
lead

Ludwig Institute for Cancer Research

OTHER